Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wagner

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Pathologie (Heidelberg, Germany)|January 11, 2023
[Clinically relevant molecular pathological diagnostics in breast cancer]Fiona R Rodepeter, Julia Teply-Szymanski, Marcel Romey, et al.
The Journal of Biological Chemistry|January 20, 2017
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in MiceSally Yu Shi, Cynthia T Luk, Stephanie A Schroer, et al.
Cell Reports|May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progressionHridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Molecular Oncology|June 14, 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesionKaire Ojasalu, Corinna Brehm, Kristin Hartung, et al.
Journal of Hematology & Oncology|October 30, 2012
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapySatyanarayana Rachagani, María P Torres, Sushil Kumar, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axisSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Cell Proliferation|June 30, 2022
Peripubertal requirement of Tsg101 in maintaining the integrity of membranous structures in mouse oocytesHyejin Shin, Dayoung Park, Jiyeon Kim, et al.
Gut|September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosisSabine Klein, Johanna Rick, Jennifer Lehmann, et al.
Journal of the National Cancer Institute|September 4, 2003
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancerAndreas du Bois, Hans-Joachim Lück, Werner Meier, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Pathologie (Heidelberg, Germany)|January 11, 2023
[Clinically relevant molecular pathological diagnostics in breast cancer]Fiona R Rodepeter, Julia Teply-Szymanski, Marcel Romey, et al.
The Journal of Biological Chemistry|January 20, 2017
Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in MiceSally Yu Shi, Cynthia T Luk, Stephanie A Schroer, et al.
Cell Reports|May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progressionHridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Molecular Oncology|June 14, 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesionKaire Ojasalu, Corinna Brehm, Kristin Hartung, et al.
Journal of Hematology & Oncology|October 30, 2012
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapySatyanarayana Rachagani, María P Torres, Sushil Kumar, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axisSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Cell Proliferation|June 30, 2022
Peripubertal requirement of Tsg101 in maintaining the integrity of membranous structures in mouse oocytesHyejin Shin, Dayoung Park, Jiyeon Kim, et al.
Gut|September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosisSabine Klein, Johanna Rick, Jennifer Lehmann, et al.
Journal of the National Cancer Institute|September 4, 2003
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancerAndreas du Bois, Hans-Joachim Lück, Werner Meier, et al.
Pageof 21